Literature DB >> 3572408

Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement.

G Paiement, S J Wessinger, A C Waltman, W H Harris.   

Abstract

Lower doses of warfarin are effective in the treatment of proven proximal deep vein thrombosis (DVT), and at a substantially lower risk of bleeding complications than with standard doses. The authors compared low-dose warfarin with external pneumatic compression (EPC) boots for prophylaxis against DVT and efficacy and safety in a population of total hip replacement patients at high risk for DVT and bleeding complications. DVT developed in 12 of 72 patients on low-dose warfarin and 11 of 66 patients on EPC. Both regimens were as efficacious as traditional higher doses of warfarin used in prior studies. No major bleeding complications occurred in either group. Low-dose warfarin appears to be an effective and relatively safe form of prophylaxis against postoperative DVT, as does sequential EPC of the calf and thigh.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572408     DOI: 10.1016/s0883-5403(87)80027-x

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

1.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.

Authors:  D K Potyk; H J Tabbarah
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

3.  Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?

Authors:  Ibrahim J Raphael; Eric H Tischler; Ronald Huang; Richard H Rothman; William J Hozack; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

4.  Can a new design of pneumatic compression device reduce variations in delivered therapy for the mechanical prophylaxis of thromboembolic disease after total hip arthroplasty?

Authors:  Bassam A Masri; David J Dunlop; James A McEwen; Donald S Garbuz; Clive P Duncan
Journal:  Can J Surg       Date:  2004-08       Impact factor: 2.089

Review 5.  Prevention and treatment of venous thromboembolism.

Authors:  G F Pineo; R D Hull
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

6.  Deep venous thrombosis following different isolated lower extremity fractures: what is known about prevalences, locations, risk factors and prophylaxis?

Authors:  S Decker; M J Weaver
Journal:  Eur J Trauma Emerg Surg       Date:  2013-02-21       Impact factor: 3.693

7.  Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.

Authors:  B J O'Brien; D R Anderson; R Goeree
Journal:  CMAJ       Date:  1994-04-01       Impact factor: 8.262

8.  Effect on deep venous thrombosis with flexion during total knee arthroplasty.

Authors:  Geoffrey H Westrich; Raz Winiarsky; Michael Betsy; Lena Maun; Thomas P Sculco
Journal:  HSS J       Date:  2006-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.